Liquid biopsy to personalize treatment for metastatic prostate cancer

被引：0

作者：

Lopez-Valcarcel, Marta ^{[1
,10
]}

Lopez-Campos, Fernando ^{[2
]}

Zafra, Juan ^{[3
]}

Cienfuegos, Irene ^{[4
]}

Ferri, Maria ^{[5
]}

Barrado, Marta ^{[6
]}

Hernando, Susana ^{[7
]}

Counago, Felipe ^{[8
,9
]}

机构：

[1] Puerta de Hierro Univ Hosp, Dept Radiat Oncol, Madrid, Spain

[2] Ramon y Cajal Univ Hosp, Dept Radiat Oncol, Madrid, Spain

[3] Virgen de la Victoria Univ Hosp, Dept Radiat Oncol, Malaga, Spain

[4] Virgen del Puerto Hosp, Dept Urol, Caceres, Extremadura, Spain

[5] Marques de Valdecilla Univ Hosp, Dept Radiat Oncol, Santander, Cantabria, Spain

[6] Univ Navarra, Dept Radiat Oncol, Pamplona, Navarra, Spain

[7] Fdn Alcorcon Univ Hosp, Dept Clin Oncol, Alcorcon, Madrid, Spain

[8] GenesisCare, San Francisco de Asis Hosp, Natl Chair Res & Clin Trials, Dept Radiat Oncol, Madrid, Spain

[9] GenesisCare, La Milagrosa Hosp, Natl Chair Res & Clin Trials, Dept Radiat Oncol, Madrid, Spain

[10] Puerta de Hierro Majadahonda Univ Hosp, Dept Radiat Oncol, C Joaquin Rodrigo 1, Majadahonda 28222, Madrid, Spain

来源：

AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH | 2024年 / 16卷 / 05期

关键词：

Liquid biopsy; prostate cancer; circulating tumor DNA; circulating tumor cells; extracellular vesicles; secretome; CIRCULATING TUMOR-CELLS; FREE DNA; PROGNOSTIC MARKERS; EXTRACELLULAR VESICLES; POOR-PROGNOSIS; BIOMARKER; PLASMA; ABIRATERONE; RESISTANCE; SURVIVAL;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Liquid biopsy is an innovative approach that provides a more complete understanding of treatment response and prognosis in monitoring metastatic prostate cancer. It complements invasive tissue biopsy and involves the assessment of various biomarkers in body fluids such as blood, semen, and urine. Liquid biopsy analyzes circulating tumor cells, extracellular vesicles, circulating tumor DNA, and the secretome. This is particularly important given the heterogeneity of prostate cancer and the need for better prognostic biomarkers. Liquid biopsy can personalize the treatment of homonosensitive and castration -resistant metastatic prostate cancer by acting as a predictive and prognostic tool. This review discusses various biomarkers, assay techniques, and potential applications in daily clinical practice, highlighting the exciting possibilities that this emerging field holds for improving patient outcomes.

引用

页码：1531 / 1549

页数：19

共 147 条

[51] Circulating Cell-Free DNA to Guide Prostate Cancer Treatment with PARP Inhibition
Goodall, Jane
Mateo, Joaquin
Yuan, Wei
Mossop, Helen
Porta, Nuria
Miranda, Susana
Perez-Lopez, Raquel
Dolling, David
Robinson, Dan R.
Sandhu, Shahneen
Fowler, Gemma
Ebbs, Berni
Flohr, Penny
Seed, George
Rodrigues, Daniel Nava
Boysen, Gunther
Bertan, Claudia
Atkin, Mark
Clarke, Matthew
Crespo, Mateus
Figueiredo, Ines
Riisnaes, Ruth
Sumanasuriya, Semini
Rescigno, Pasquale
Zafeiriou, Zafeiris
Sharp, Adam
Tunariu, Nina
Bianchini, Diletta
Gillman, Alexa
Lord, Christopher J.
Hall, Emma
Chinnaiyan, Arul M.
Carreira, Suzanne
de Bono, Johann S.
[J]. CANCER DISCOVERY, 2017, 7 (09) : 1006 - 1017
[52] Circulating Tumor Cells as a Predictive Biomarker in Patients With Hormone-sensitive Prostate Cancer
Goodman, Oscar B., Jr.
Symanowski, James T.
Loudyi, Aida
Fink, Louis M.
Ward, David C.
Vogelzang, Nicholas J.
[J]. CLINICAL GENITOURINARY CANCER, 2011, 9 (01) : 31 - 38
[53] Effects of exosomes on pre-metastatic niche formation in tumors
Guo, Yaxin
Ji, Xiang
Liu, Jinbo
Fan, Dandan
Zhou, Quanbo
Chen, Chen
Wang, Weiwei
Wang, Guixian
Wang, Haijiang
Yuan, Weitang
Ji, Zhenyu
Sun, Zhenqiang
[J]. MOLECULAR CANCER, 2019, 18 (1)
[54] Discordant and heterogeneous clinically relevant genomic alterations in circulating tumor cells vs plasma DNA from men with metastatic castration resistant prostate cancer
Gupta, Santosh
Hovelson, Daniel H.
Kemeny, Gabor
Halabi, Susan
Foo, Wen-Chi
Anand, Monika
Somarelli, Jason A.
Tomlins, Scott A.
Antonarakis, Emmanuel S.
Luo, Jun
Dittamore, Ryan, V
George, Daniel J.
Rothwell, Colin
Nanus, David M.
Armstrong, Andrew J.
Gregory, Simon G.
[J]. GENES CHROMOSOMES & CANCER, 2020, 59 (04) : 225 - 239
[55] Impact of baseline serum IL-8 on metastatic hormone-sensitive prostate cancer outcomes in the Phase 3 CHAARTED trial (E3805)
Harshman, Lauren C.
Wang, Victoria X.
Hamid, Anis A.
Santone, Gabriella
Drake, Charles G.
Carducci, Michael A.
DiPaola, Robert S.
Fichorova, Raina N.
Sweeney, Christopher J.
[J]. PROSTATE, 2020, 80 (16) : 1429 - 1437
[56] Cell-free DNA in the management of prostate cancer: Current status and future prospective
He, Wei
Xiao, Yutian
Yan, Shi
Zhu, Yasheng
Ren, Shancheng
[J]. ASIAN JOURNAL OF UROLOGY, 2023, 10 (03) : 298 - 316
[57] Circulating Tumor Cell Number as a Response Measure of Prolonged Survival for Metastatic Castration-Resistant Prostate Cancer: A Comparison With Prostate-Specific Antigen Across Five Randomized Phase III Clinical Trials
Heller, Glenn
McCormack, Robert
Kheoh, Thian
Molina, Arturo
Smith, Matthew R.
Dreicer, Robert
Saad, Fred
de Wit, Ronald
Aftab, Dana T.
Hirmand, Mohammad
Limon, Ana
Fizazi, Karim
Fleisher, Martin
de Bono, Johann S.
Scher, Howard I.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06) : 572 - +
[58] Epigenetic markers in circulating cell-free DNA as prognostic markers for survival of castration-resistant prostate cancer patients
Hendriks, Rianne J.
Dijkstra, Siebren
Smit, Frank P.
Vandersmissen, Johan
Van de Voorde, Hendrik
Mulders, Peter F. A.
van Oort, Inge M.
Van Criekinge, Wim
Schalken, Jack A.
[J]. PROSTATE, 2018, 78 (05) : 336 - 342
[59] Activating AKT1 and PIK3CA Mutations in Metastatic Castration-Resistant Prostate Cancer
Herberts, Cameron
Murtha, Andrew J.
Fu, Simon
Wang, Gang
Schonlau, Elena
Xue, Hui
Lin, Dong
Gleave, Anna
Yip, Steven
Angeles, Arkhjamil
Hotte, Sebastien
Tran, Ben
North, Scott
Taavitsainen, Sinja
Beja, Kevin
Vandekerkhove, Gillian
Ritch, Elie
Warner, Evan
Saad, Fred
Iqbal, Nayyer
Nykter, Matti
Gleave, Martin E.
Wang, Yuzhuo
Annala, Matti
Chi, Kim N.
Wyatt, Alexander W.
[J]. EUROPEAN UROLOGY, 2020, 78 (06) : 834 - 844
[60] Multiparametric liquid biopsy analysis in metastatic prostate cancer
Hodara, Emmanuelle
Morrison, Gareth
Cunha, Alexander
Zainfeld, Daniel
Xu, Tong
Xu, Yucheng
Dempsey, Paul W.
Pagano, Paul C.
Bischoff, Farideh
Khurana, Aditi
Koo, Samuel
Ting, Marc
Cotter, Philip D.
Moore, Mathew W.
Gunn, Shelly
Usher, Joshua
Rabizadeh, Shahrooz
Danenberg, Peter
Danenberg, Kathleen
Carpten, John
Dorff, Tanya
Quinn, David
Goldkorn, Amir
[J]. JCI INSIGHT, 2019, 4 (05)

← 1 2 3 4 5 6 7 8 9 10 →